{
  "api": "assay-systems/v1",
  "key_tier": "none",
  "retrieved": "2026-10-16T18:15:56Z",
  "source": "Assay Systems register, https://assay-systems.com/register/",
  "access_notice": "On 15 November 2026, automated access to assay-systems.com closes. After that date, access is available only under a paid annual subscription contract. Contact: contact@assay-systems.com",
  "data": {
    "id": "ASY-CA-1UJ5DPF0FS",
    "type": "grant",
    "country": "ca",
    "name": "Novocol Pharmaceutical of Canada Inc.: federal grants and contributions",
    "url": "https://assay-systems.com/register/ca/grants/r/novocol-pharmaceutical-of-canada-inc/",
    "summary": "2 federal grant and contribution agreements worth $33.2M with Novocol Pharmaceutical of Canada Inc., 2020–2021.",
    "figures": [
      {
        "label": "agreements",
        "value": 2,
        "unit": "count"
      },
      {
        "label": "value",
        "value": 33200000.000000004,
        "unit": "money",
        "currency": "CAD",
        "approximate": true,
        "display": "$33.2M"
      },
      {
        "label": "departments",
        "value": 2,
        "unit": "count"
      },
      {
        "label": "programs",
        "value": 2,
        "unit": "count"
      }
    ],
    "text": [
      "This project will support the expansion of existing bio-manufacturing facilities and increasing fill-finish capacity for vaccines/therapies, including live and viral vector vaccines.",
      "Design of a facility, inclusive of engineering design and research in innovative formulation and fill-finish manufacturing of vaccines, therapies and other biopharmaceuticals using a Ready-To-Use (RTU) container platform for vials and prefilled syringes. Novocol Pharma is a world-class commercial aseptic fill-finish operation with multiple fill-finish suites and scientific/technical support departments (Microbiology, Chemistry, Product Development, Engineering, Validation, Stability and Analytical Services). An existing warehouse building will be renovated to create injectable vaccine/therap"
    ],
    "records": [
      {
        "name": "grants and contributions register",
        "url": "https://assay-systems.com/register/ca/grants/"
      },
      {
        "name": "Cambridge",
        "url": "https://assay-systems.com/register/ca/grants/riding/35016-cambridge/"
      },
      {
        "name": "Innovation, Science and Economic Development Canada",
        "url": "https://assay-systems.com/register/ca/grants/department/innovation-science-and-economic-development-canada/"
      },
      {
        "name": "National Research Council Canada",
        "url": "https://assay-systems.com/register/ca/grants/department/national-research-council-canada/"
      }
    ],
    "assay_record": "ASY-CA-1UJ5DPF0FS",
    "cite_as": "Assay Systems, \"Novocol Pharmaceutical of Canada Inc.: federal grants and contributions\", https://assay-systems.com/register/ca/grants/r/novocol-pharmaceutical-of-canada-inc/"
  }
}